338 related articles for article (PubMed ID: 6282937)
21. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.
Gianturco SH; Lin AH; Hwang SL; Young J; Brown SA; Via DP; Bradley WA
J Clin Invest; 1988 Nov; 82(5):1633-43. PubMed ID: 3183059
[TBL] [Abstract][Full Text] [Related]
22. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway.
Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S
Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460
[TBL] [Abstract][Full Text] [Related]
23. Is hypertriglyceridemic very low density lipoprotein a precursor of normal low density lipoprotein?
Oschry Y; Olivecrona T; Deckelbaum RJ; Eisenberg S
J Lipid Res; 1985 Feb; 26(2):158-67. PubMed ID: 3989374
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of cholesteryl esters and triglycerides in cultured macrophages incubated with plasma very low density lipoproteins from rats fed on casein or soybean protein diets containing moderate levels of cholesterol.
Eklund A; Sjöblom L; Ostlund-Lindqvist AM
Atherosclerosis; 1986 Nov; 62(2):129-36. PubMed ID: 3801080
[TBL] [Abstract][Full Text] [Related]
25. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts.
Gianturco SH; Brown FB; Gotto AM; Bradley WA
J Lipid Res; 1982 Sep; 23(7):984-93. PubMed ID: 6292317
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.
Innerarity TL; Arnold KS; Weisgraber KH; Mahley RW
Arteriosclerosis; 1986; 6(1):114-22. PubMed ID: 3942555
[TBL] [Abstract][Full Text] [Related]
27. Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase.
Hendriks WL; van der Sman-de Beer F; van Vlijmen BJ; van Vark LC; Hofker MH; Havekes LM
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):498-504. PubMed ID: 9102168
[TBL] [Abstract][Full Text] [Related]
28. Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages.
Klein RL; Lyons TJ; Lopes-Virella MF
Metabolism; 1989 Nov; 38(11):1108-14. PubMed ID: 2554094
[TBL] [Abstract][Full Text] [Related]
29. Relative importance of the LDL receptor and scavenger receptor class B in the beta-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages.
Herijgers N; Van Eck M; Korporaal SJ; Hoogerbrugge PM; Van Berkel TJ
J Lipid Res; 2000 Jul; 41(7):1163-71. PubMed ID: 10884299
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
[TBL] [Abstract][Full Text] [Related]
31. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages.
Lindqvist P; Ostlund-Lindqvist AM; Witztum JL; Steinberg D; Little JA
J Biol Chem; 1983 Aug; 258(15):9086-92. PubMed ID: 6874679
[TBL] [Abstract][Full Text] [Related]
32. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia.
Fainaru M; Mahley RW; Hamilton RL; Innerarity TL
J Lipid Res; 1982 Jul; 23(5):702-14. PubMed ID: 7119569
[TBL] [Abstract][Full Text] [Related]
33. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages.
Whitman SC; Hazen SL; Miller DB; Hegele RA; Heinecke JW; Huff MW
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1238-49. PubMed ID: 10323775
[TBL] [Abstract][Full Text] [Related]
34. Very low density lipoproteins promote triglyceride accumulation in macrophages.
Bates SR; Murphy PL; Feng ZC; Kanazawa T; Getz GS
Arteriosclerosis; 1984; 4(2):103-14. PubMed ID: 6704048
[TBL] [Abstract][Full Text] [Related]
35. Failure of the intracellular itinerary of beta very low density lipoproteins to augment cholesterol esterification in macrophages from Watanabe heritable hyperlipidemic rabbits.
Daugherty A; Rateri DL
J Biol Chem; 1991 Sep; 266(26):17269-75. PubMed ID: 1894618
[TBL] [Abstract][Full Text] [Related]
36. Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
Takahashi S
J Atheroscler Thromb; 2017 Jun; 24(6):552-559. PubMed ID: 28428482
[TBL] [Abstract][Full Text] [Related]
37. Beta-migrating very low density lipoproteins induce foam cell formation in mouse mesangial cells.
Nishikawa T; Kobori S; Takeda H; Higashi T; Sato Y; Sasahara T; Yano T; Kasho M; Anami Y; Shichiri M
Atherosclerosis; 1995 Apr; 114(1):123-32. PubMed ID: 7605371
[TBL] [Abstract][Full Text] [Related]
38. Abnormalities of composition and of in vitro lipolysis products of human small very low density lipoproteins in hypertriglyceridemia.
Tornvall P; Hamsten A; Carlson LA
Atherosclerosis; 1990 May; 82(1-2):125-35. PubMed ID: 2360914
[TBL] [Abstract][Full Text] [Related]
39. Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor.
Suzuki J; Takahashi S; Oida K; Shimada A; Kohno M; Tamai T; Miyabo S; Yamamoto T; Nakai T
Biochem Biophys Res Commun; 1995 Jan; 206(3):835-42. PubMed ID: 7832794
[TBL] [Abstract][Full Text] [Related]
40. Secretion of cholesteryl ester-enriched very low density lipoproteins by the liver of cholesterol-fed rabbits.
MacKinnon AM; Savage J; Gibson RA; Barter PJ
Atherosclerosis; 1985 Feb; 54(2):145-55. PubMed ID: 3986014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
